0001678660-20-000001.txt : 20200828
0001678660-20-000001.hdr.sgml : 20200828
20200828140930
ACCESSION NUMBER: 0001678660-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200828
DATE AS OF CHANGE: 20200828
EFFECTIVENESS DATE: 20200828
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-374395
FILM NUMBER: 201147061
BUSINESS ADDRESS:
STREET 1: 550 S COLLEGE AVE.
CITY: NEWARK
STATE: DE
ZIP: 19713
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 550 S COLLEGE AVE.
CITY: NEWARK
STATE: DE
ZIP: 19713
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
D
1
primary_doc.xml
X0708
D
LIVE
0001678660
Prelude Therapeutics Inc
200 Powder Mill Road
Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
(302) 547-3768
DELAWARE
Prelude Therapeutics Inc.
Corporation
true
2016
Krishna
Vaddi
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Director
Paul
Friedman
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Director
David
Bonita
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Director
Kelvin
Neu
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Director
Victor
Sandor
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Director
Mardi
C.
Dier
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Director
Peggy
Scherle
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Andrew
Combs
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Brian
Piper
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
David
Mauro
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Christopher
Pierce
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Deborah
Morosini
c/o Prelude Therapeutics Inc, 200 Powder
Mill Rd, Experimental Station E400/3213
Wilmington
DE
DELAWARE
19803
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2020-08-21
false
true
false
0
49999969
49999969
0
false
7
0
0
0
false
Prelude Therapeutics Inc
/s/ Krishna Vaddi
Krishna Vaddi
Chief Executive Officer
2020-08-28